Simplex Trading’s UroGen Pharma URGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.53M | Buy |
185,030
+184,698
| +55,632% | +$2.53M | ﹤0.01% | 195 |
|
|
2025
Q1 | $3K | Buy |
+332
| New | +$3K | ﹤0.01% | 2075 |
|
|
2024
Q4 | – | Sell |
-19,031
| Closed | -$241K | – | 4092 |
|
|
2024
Q3 | $241K | Buy |
19,031
+8,412
| +79% | +$107K | ﹤0.01% | 824 |
|
|
2024
Q2 | $178K | Buy |
10,619
+7,814
| +279% | +$131K | ﹤0.01% | 952 |
|
|
2024
Q1 | $42K | Sell |
2,805
-3,846
| -58% | -$57.6K | ﹤0.01% | 1450 |
|
|
2023
Q4 | $99K | Buy |
6,651
+3,501
| +111% | +$52.1K | ﹤0.01% | 1181 |
|
|
2023
Q3 | $44K | Sell |
3,150
-31,189
| -91% | -$436K | ﹤0.01% | 1258 |
|
|
2023
Q2 | $355K | Sell |
34,339
-622
| -2% | -$6.43K | ﹤0.01% | 664 |
|
|
2023
Q1 | $323K | Buy |
34,961
+31,661
| +959% | +$293K | ﹤0.01% | 655 |
|
|
2022
Q4 | $29K | Sell |
3,300
-545
| -14% | -$4.79K | ﹤0.01% | 1492 |
|
|
2022
Q3 | $31K | Buy |
3,845
+3,725
| +3,104% | +$30K | ﹤0.01% | 1595 |
|
|
2022
Q2 | $0 | Sell |
120
-166
| -58% | – | ﹤0.01% | 4271 |
|
|
2022
Q1 | $2K | Buy |
286
+87
| +44% | +$608 | ﹤0.01% | 2645 |
|
|
2021
Q4 | $1K | Buy |
199
+190
| +2,111% | +$955 | ﹤0.01% | 2854 |
|
|
2021
Q3 | $0 | Hold |
9
| – | – | ﹤0.01% | 3814 |
|
|
2021
Q2 | $0 | Sell |
9
-352
| -98% | – | ﹤0.01% | 3962 |
|
|
2021
Q1 | $7K | Buy |
361
+75
| +26% | +$1.45K | ﹤0.01% | 2220 |
|
|
2020
Q4 | $5K | Buy |
+286
| New | +$5K | ﹤0.01% | 2053 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 3259 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 3152 |
|
|
2020
Q1 | – | Sell |
-12,262
| Closed | -$409K | – | 3123 |
|
|
2019
Q4 | $409K | Buy |
12,262
+5,504
| +81% | +$184K | ﹤0.01% | 514 |
|
|
2019
Q3 | $161K | Buy |
+6,758
| New | +$161K | ﹤0.01% | 711 |
|